In vitro modulation of MCF-7 breast cancer cell growth by myoepithelial cells

Author(s):  
D Bani ◽  
L Magnelli ◽  
O Gallo
2013 ◽  
Vol 65 (3) ◽  
pp. 460-468 ◽  
Author(s):  
Meilan Xue ◽  
Yinlin Ge ◽  
Jinyu Zhang ◽  
Yongchao Liu ◽  
Qing Wang ◽  
...  

2009 ◽  
Vol 120 (1) ◽  
pp. 253-260 ◽  
Author(s):  
Ramon C. Sun ◽  
Mitali Fadia ◽  
Jane E. Dahlstrom ◽  
Christopher R. Parish ◽  
Philip G. Board ◽  
...  

2012 ◽  
Vol 12 (1) ◽  
pp. 1233-1238 ◽  
Author(s):  
YING WANG ◽  
LEQIU WANG ◽  
CHANGHAO YIN ◽  
BAIZHU AN ◽  
YANKUN HAO ◽  
...  

Oncotarget ◽  
2016 ◽  
Vol 7 (8) ◽  
pp. 9250-9270 ◽  
Author(s):  
Monica Benvenuto ◽  
Laura Masuelli ◽  
Enrico De Smaele ◽  
Massimo Fantini ◽  
Rosanna Mattera ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Marina Makrecka-Kuka ◽  
Pavels Dimitrijevs ◽  
Ilona Domracheva ◽  
Kristaps Jaudzems ◽  
Maija Dambrova ◽  
...  

AbstractThe development of targeted drugs for the treatment of cancer remains an unmet medical need. This study was designed to investigate the mechanism underlying breast cancer cell growth suppression caused by fused isoselenazolium salts. The ability to suppress the proliferation of malignant and normal cells in vitro as well as the effect on NAD homeostasis (NAD+, NADH, and NMN levels), NAMPT inhibition and mitochondrial functionality were studied. The interactions of positively charged isoselenazolium salts with the negatively charged mitochondrial membrane model were assessed. Depending on the molecular structure, fused isoselenazolium salts display nanomolar to high micromolar cytotoxicities against MCF-7 and 4T1 breast tumor cell lines. The studied compounds altered NMN, NAD+, and NADH levels and the NAD+/NADH ratio. Mitochondrial functionality experiments showed that fused isoselenazolium salts inhibit pyruvate-dependent respiration but do not directly affect complex I of the electron transfer system. Moreover, the tested compounds induce an immediate dramatic increase in the production of reactive oxygen species. In addition, the isoselenazolothiazolium derivative selectively binds to cardiolipin in a liposomal model. Isoselenazolium salts may be a promising platform for the development of potent drug candidates for anticancer therapy that impact mitochondrial pyruvate-dependent metabolism in breast cancer cells.


1998 ◽  
Vol 130 (1-2) ◽  
pp. 143-152 ◽  
Author(s):  
Laura Fioravanti ◽  
Vera Cappelletti ◽  
Patrizia Miodini ◽  
Enrico Ronchi ◽  
Moreno Brivio ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document